MarketWatch
Lilly’s new GLP-1 pill is off to a ‘robust’ start
Lilly’s new GLP-1 pill had 1,390 prescriptions in its first week on the market.
M
Source
MarketWatch
Read full article at MarketWatch
Opens original article in a new tab
Advertisement
AI Bias Analysis
4 models · Takes ~15 seconds
Related Economy Stories
Bloomberg Markets
US May Unfreeze $20 Billion in Funds for Iran’s Uranium: Axios
The Trump administration is said to be considering a deal to unfreeze $20 billion in Iranian assets in exchange for Iran’s uranium stockpiles, according to an Axios report. Tyler Kendall reports on Bloomberg Television. (Source: Bloomberg)
Bloomberg Markets
Rep. Hill Says Time to Move on From Powell Case and Confirm Warsh
Rep. French Hill, a Republican from Arkansas, discusses the upcoming confirmation process for Kevin Warsh, President Donald Trump’s nominee for Federal Reserve Chair. (Source: Bloomberg)
Bloomberg Markets
EQT Warns of Exit Risks for Alternative Energy Assets Held by PE
EQT AB, Europe’s biggest private equity firm, says the path to exiting investments in clean-energy developers and operators faces a growing number of hurdles.
Forbes
97% Of Americans Support NASA’s Artemis — Despite $90 Billion Cost
Americans show strong support for NASA’s Artemis program despite its cost, with nearly one-third described it as a unifying moment.